Signaling Mechanisms of Lens Development
- Institution
- COLUMBIA UNIVERSITY HEALTH SCIENCES, NY
- Principal investigator
- Xin Zhang
- Funding
- $1.6M
- Duration
- 2006–2028
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Defective lens development is a major cause of congenital eye diseases, because the human lens is the culmination of elaborate cell proliferation, differentiation and morphogenesis, requiring precise regulation by signaling pathways. A molecular understanding of lens development could potentially lead to new ways of diagnosing and treating congenital eye diseases originating from defective lens genesis. We have previously demonstrated that Abl tyrosine kinase modulates actin cytoskeleton remodeling to prevent persistent lens stalk, a hallmark of Peters anomaly. In this application, we will investigate the direct targets of Abl kinases. Using conditional mutant mice and cell culture models, we will identify protein tyrosine phosphatase Ptpn12 as a novel substrate of Abl signaling. Furthermore, we will test the hypothesis that Cas and Paxillin cooperate to induce Crk signaling in lens morphogenesis. Lastly, we will investigate the role of regulation of Abl interactor Abi in the lens. As a major signaling pathway, perturbation in Abl signaling can cause not only congenital disorders but also inflammation, neural degeneration and cancer. Therefore, the study of Abl signaling has far- reaching implications for both human health and vision research.
LOADING MOONBASE SCORE
Questions for COLUMBIA UNIVERSITY HEALTH SCIENCES
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Columbia University Health SciencesNot yet scored
Integrating biomechanical and biochemical signaling in lacrimal gland development
Xin Zhang · $506K · 2009–2030
- NIH · Columbia University Health Sciences70
Causal Gene Prioritization in Systemic Sclerosis: Multi-Omics Analyses from Population Genetics to Single Cell Biology
Yiming Luo · $173K · 2025–2030
- NIH · Columbia University Health Sciences48
Metformin in Alzheimer's dementia Prevention (MAP)
Daniel F Hanley · $6.5M · 2019–2026